Last reviewed · How we verify
Primary ovarian failure
Approved treatments
- Delestrogen · Ph Health
Delestrogen works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Micronor · Johnson & Johnson
ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects. - Estrace · Pfizer
Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Menest · Pfizer Inc.
Esterified estrogens, sold under the brand names Estratab and Menest, are used for hormone therapy and cancer treatment. - Estring · Pfizer Inc.
Prevents pregnancy primarily by suppressing ovulation. - Depoestradiol · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Primary ovarian failure patent landscape — cliff calendar, originator estates, attackable patents
- Primary ovarian failure treatment landscape brief
- Primary ovarian failure treatment updates RSS
Frequently asked questions about Primary ovarian failure
What drugs treat Primary ovarian failure?
Tracked treatments include Delestrogen, Micronor, Estrace, Menest, Estring, Depoestradiol.
What is the treatment for Primary ovarian failure?
Standard treatment for Primary ovarian failure includes Delestrogen, Micronor, Estrace, Menest, Estring. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Primary ovarian failure patent cliff · Primary ovarian failure CI report
- Treatment: Delestrogen · Ph Health
- Treatment: Micronor · Johnson & Johnson
- Treatment: Estrace · Pfizer
- Treatment: Menest · Pfizer Inc.
- Treatment: Estring · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing